Healthcare intellectual property commercialisation group NetScientific announced on Wednesday that its portfolio company Vortex Biosciences has appointed Bob Englert as its chief executive officer.
Healthcare commercialisation group NetScientific announced on Monday that its portfolio company Wanda has achieved highly positive results in a study with congestive heart failure patients.
Healthcare intellectual property commercialisation company NetScientific announced on Monday that its portfolio company Wanda Health is expanding into orthopedics through a new partnership with HRS Home Health.
NetScientific announced on Thursday that its portfolio company, ProAxsis, has secured the first sale of NEATstik to a research laboratory conducting a respiratory clinical trial.
Healthcare intellectual property commercialisation group Netscientific has today highlighted a positive report displaying the potential of Vortex Technology in cancer treatment.
NetScientific, the transatlantic healthcare IP commercialisation group, has today announced that ProAxsis, its portfolio company in which it holds a 57% stake, is forecasting higher direct sales of its ProteaseTag Active Neutrophil Elastase Immunoassay.
Healthcare intellectual property commercialisation group NetScientific noted on Tuesday that its portfolio company, Vortex BioSciences, has announced its first direct commercial sale of its VTX-1 Liquid Biopsy System - a fully automated benchtop system for collecting intact circulating tumour cells (CTCs).
NetScientific said that its Wanda health management technology had been adopted by US-based HRS Home Health to help it monitor all the patients in its care.
Healthcare intellectual property commercialisation company NetScientific announced on Thursday that a Chinese patent exclusively licensed to one of its portfolio companies, Glycotest, has been allowed.
Transatlantic healthcare intellectual property commercialisation group NetScientific announced the issue by the US Patent and Trademark Office of a new patent exclusively licensed to its portfolio company, Wanda, on Monday.
Health care intellectual property commercialisation group NetScientific announced an update for its portfolio company ProAxsis on Thursday.
Healthcare intellectual property commercialisation group NetScientific updated the market on its portfolio company ProAxsis on Monday, confirming ProAxsis had signed an agreement to develop activity-based immunoassays for "two key respiratory proteases", using its ProteaseTag technology.
NetScientific updated the market on its portfolio company ProAxsis on Monday confirming it had now gained further support for its 'ProteaseTag' technology through a project co-funded by Innovate UK.
Healthcare intellectual property commercialisation firm NetScientific's portfolio company Wanda has sold its stake in OncoVerse to BTG, a pharmaceutical, for an undisclosed sum.
Healthcare intellectual property commercialisation group NetScientific announced on Wednesday that its portfolio company, Vortex Biosciences, had begun the commercial launch of the VTX1 Liquid Biopsy System.
Healthcare intellectual property company NetScientific said it had appointed Google alum Foad Dabiri chief executive of its San Francisco-based portfolio company Wanda, with immediate effect.
NetScientific, a healthcare company which commercialises intellectual property, reported a wider loss before tax in the first half the year while many of its core portfolio companies have made progress.
Biomedical and healthcare technology company NetScientific's portfolio business, Vortex Biosciences, won a license to four patents from Harvard University.
NetScientific's losses widened in 2015, it reported on Thursday, though it was optimistic about the future having completed a radical restructure of its management and portfolio during the 12 months.
NetScientific added a big name in the British medical industry to its board on Wednesday, announcing the appointment of Professor Stephen Smith as a non-executive director.